S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function i⦠(NCT00090961) | Clinical Trial Compass
TerminatedNot Applicable
S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
Stopped: Closed early due to poor accrual.
United States2 participantsStarted 2004-09
Plain-language summary
RATIONALE: Pulmonary rehabilitation education and exercise training may improve physical function and quality of life in patients who are receiving treatment for lung cancer.
PURPOSE: This randomized clinical trial is studying pulmonary rehabilitation education and exercise training to see how well they work compared to exercise training alone in improving physical function and quality of life in patients who are undergoing chemotherapy and radiation therapy for locally advanced lung cancer.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed single, primary bronchogenic lung cancer
* Inoperable, locally advanced disease (unresectable stage IIIA OR stage IIIB disease)
* The following histologies are eligible:
* Adenocarcinoma
* Large cell carcinoma
* Squamous cell carcinoma
* Non-lobar and non-diffuse bronchoalveolar carcinoma
* Small cell lung cancer
* Must have received chemotherapy (platinum based) and radiotherapy for locally advanced unresectable lung cancer
* Must have achieved a complete response, partial response, or stable disease after treatment
PATIENT CHARACTERISTICS:
Age
* Not specified
Performance status
* Zubrod 0-2
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Cardiovascular
* No acute EKG changes, arrhythmia, or other cardiac abnormality that would preclude study participation
* No uncontrolled cardiac disease
* No recent myocardial infarction
Pulmonary
* Any FEV\_1 level by pulmonary function testing
Other
* Willing to participate in 12-week long exercise program
* Chemotherapy-induced neuropathy ⤠grade 2
* No uncontrolled diabetes mellitus
* No other medical condition that would preclude study participation
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* See Disease Characteristics
Endocrine therapy
* Not specified
Radiotherapy
* See Disease Characteristics
Surgery
* Not specified